Primary |
Rheumatoid Arthritis |
60.0% |
Drug Use For Unknown Indication |
40.0% |
|
Neutropenia |
50.0% |
Vomiting |
50.0% |
|
Secondary |
Drug Use For Unknown Indication |
16.6% |
Product Used For Unknown Indication |
13.3% |
Back Pain |
9.4% |
Pain |
6.9% |
Cholelithiasis |
5.9% |
Rheumatoid Arthritis |
5.4% |
Cholecystectomy |
5.1% |
Influenza |
5.1% |
Hypertension |
4.3% |
Headache |
4.1% |
Toothache |
3.8% |
Haemorrhoids |
3.6% |
Sciatica |
3.3% |
Arthralgia |
3.1% |
Bipolar I Disorder |
2.0% |
Polyarthritis |
2.0% |
Breast Cancer |
1.8% |
Non-small Cell Lung Cancer |
1.5% |
Psoriatic Arthropathy |
1.5% |
Diabetes Mellitus |
1.3% |
|
Renal Failure Acute |
19.0% |
Vomiting |
15.5% |
Stevens-johnson Syndrome |
8.3% |
Reversible Posterior Leukoencephalopathy Syndrome |
7.1% |
Toxic Skin Eruption |
6.0% |
Hepatitis Cholestatic |
4.8% |
Mitral Valve Incompetence |
4.8% |
Inappropriate Antidiuretic Hormone Secretion |
3.6% |
Thrombocytopenia |
3.6% |
Urticaria |
3.6% |
Chills |
2.4% |
Cytolytic Hepatitis |
2.4% |
Fall |
2.4% |
Genital Ulceration |
2.4% |
Headache |
2.4% |
Migraine |
2.4% |
Overdose |
2.4% |
Rash Maculo-papular |
2.4% |
Respiratory Distress |
2.4% |
Rib Fracture |
2.4% |
|
Concomitant |
Rheumatoid Arthritis |
15.4% |
Drug Use For Unknown Indication |
14.7% |
Product Used For Unknown Indication |
13.6% |
Pain |
9.4% |
Psoriatic Arthropathy |
8.2% |
Hypertension |
6.3% |
Prophylaxis |
4.2% |
Back Pain |
4.0% |
Musculoskeletal Chest Pain |
2.7% |
Ankylosing Spondylitis |
2.5% |
Nausea |
2.5% |
Type 2 Diabetes Mellitus |
2.5% |
Gastrooesophageal Reflux Disease |
2.2% |
Osteitis Deformans |
2.2% |
Neuralgia |
1.8% |
Psoriasis |
1.8% |
Breast Cancer |
1.6% |
Depression |
1.4% |
Hypercholesterolaemia |
1.4% |
Influenza Like Illness |
1.4% |
|
Vomiting |
11.5% |
Urticaria |
8.2% |
Hyponatraemia |
6.6% |
Pyrexia |
6.6% |
Renal Failure Acute |
6.6% |
Pulmonary Fibrosis |
4.9% |
Rheumatoid Arthritis |
4.9% |
Sinusitis |
4.9% |
Tendon Rupture |
4.9% |
Tenosynovitis |
4.9% |
Transaminases Increased |
4.9% |
Weight Increased |
4.9% |
Cytolytic Hepatitis |
3.3% |
Eosinophilia |
3.3% |
Hepatocellular Injury |
3.3% |
Hypersensitivity Vasculitis |
3.3% |
Intraocular Pressure Increased |
3.3% |
Malignant Melanoma |
3.3% |
Oedema |
3.3% |
Osteonecrosis |
3.3% |
|
Interacting |
Drug Use For Unknown Indication |
23.3% |
Acute Myeloid Leukaemia |
17.4% |
Myocardial Ischaemia |
9.3% |
Hypertension |
5.8% |
Osteoarthritis |
5.8% |
Pneumocystis Jiroveci Pneumonia |
5.8% |
Sciatica |
5.8% |
Pain |
4.7% |
Type 2 Diabetes Mellitus |
4.7% |
Atrial Fibrillation |
3.5% |
Epilepsy |
2.3% |
Insulin-requiring Type 2 Diabetes Mellitus |
2.3% |
Pain In Extremity |
2.3% |
Arthritis |
1.2% |
Back Pain |
1.2% |
Chronic Myeloid Leukaemia |
1.2% |
Gout |
1.2% |
Hypercholesterolaemia |
1.2% |
Product Used For Unknown Indication |
1.2% |
|
Vomiting |
27.8% |
Transaminases Increased |
16.7% |
Drug Interaction |
11.1% |
Renal Failure Acute |
11.1% |
Respiratory Distress |
11.1% |
Subcutaneous Emphysema |
11.1% |
Optic Neuritis |
5.6% |
Weight Decreased |
5.6% |
|